BAY-43-9006 in Advanced, Metastatic Soft Tissue Sarcomas
NCT00406601
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
69
Enrollment
OTHER
Sponsor class
Conditions
Sarcoma, Soft Tissue
Interventions
DRUG:
Sorafenib (BAY-43-9006)
Sponsor
Istituto Clinico Humanitas